Heterogeneous distribution of myocardial steatosis - An ex vivo evaluation

Magnetic Resonance in Medicine

Volumn 68, Issue 1, 2012, Pages 1-7

  Liu, Chia Ying ^a   Liu, Yuan Chang ^a   Venkatesh, Bharath Ambale ^a   Lima, Joao A C ^a   Bluemke, David A ^a,b   Steenbergen, Charles ^c  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

Cardiac steatosis; Ex vivo; Heterogeneity; Magnetic resonance spectroscopy

Indexed keywords

CARDIOLOGY; MAGNETIC RESONANCE SPECTROSCOPY; MAGNETISM; NUCLEAR MAGNETIC RESONANCE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

BEATING HEART; CARDIAC STEATOSIS; CARDIO-VASCULAR DISEASE; CIRCUMFERENTIAL LOCATION; EX-VIVO; FAT ACCUMULATION; HETEROGENEITY; HETEROGENEOUS DISTRIBUTIONS;

DISEASES;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CAUSE OF DEATH; CORRELATION ANALYSIS; EX VIVO STUDY; FAT CONTENT; FEMALE; HEART VENTRICLE SEPTUM; HUMAN; HUMAN TISSUE; LIPID COMPOSITION; LIPID STORAGE; MAJOR CLINICAL STUDY; MALE; MYOCARDIAL DISEASE; MYOCARDIAL STEATOSIS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROTON NUCLEAR MAGNETIC RESONANCE; TISSUE DISTRIBUTION; TISSUE SLICE;

EID: 84862258433     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.24332     Document Type: Article

References (30)

1. Adams LA, Lymp JF, St Sauver J, Sanderson SO, Lindor KD, Feldstein A, Angulo P. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 2005;129: 113-121. (Pubitemid 41002048)
2. Chiu HC, Kovacs A, Ford DA, Hsu FF, Garcia R, Herrero P, Saffitz JE, Schaffer JE. A novel mouse model of lipotoxic cardiomyopathy. J Clin Invest 2001;107:813-822. (Pubitemid 32274034)
3. Hirose H, Lee YH, Inman LR, Nagasawa Y, Johnson JH, Unger RH. Defective fatty acid-mediated beta-cell compensation in Zucker diabetic fatty rats. Pathogenic implications for obesity-dependent diabetes. J Biol Chem 1996;271:5633-5637.
4. McGavock JM, Victor RG, Unger RH, Szczepaniak LS. Adiposity of the heart, revisited. Ann Intern Med 2006;144:517-524. (Pubitemid 46780675)
5. Szczepaniak LS, Victor RG, Orci L, Unger RH. Forgotten but not gone: the rediscovery of fatty heart, the most common unrecognized disease in America. Circ Res 2007;101:759-767. (Pubitemid 350287190)
6. Schaffer JE. Lipotoxicity: when tissues overeat. Curr Opin Lipidol 2003;14:281-287. (Pubitemid 36688207)
7. Unger RH, Orci L. Lipoapoptosis: its mechanism and its diseases. Biochim Biophys Acta 2002;1585:202-212. (Pubitemid 36092084)
8. Christoffersen C, Bollano E, Lindegaard ML, Bartels ED, Goetze JP, Andersen CB, Nielsen LB. Cardiac lipid accumulation associated with diastolic dysfunction in obese mice. Endocrinology 2003;144: 3483-3490. (Pubitemid 36904426)
9. McGavock JM, Lingvay I, Zib I, Tillery T, Salas N, Unger R, Levine BD, Raskin P, Victor RG, Szczepaniak LS. Cardiac steatosis in diabetes mellitus: a 1H-magnetic resonance spectroscopy study. Circulation 2007;116:1170-1175. (Pubitemid 47360218)
10. Reingold JS, McGavock JM, Kaka S, Tillery T, Victor RG, Szczepaniak LS. Determination of triglyceride in the human myocardium by magnetic resonance spectroscopy: reproducibility and sensitivity of the method. Am J Physiol Endocrinol Metab 2005;289:E935-E939. (Pubitemid 41504396)
11. Szczepaniak LS, Dobbins RL, Metzger GJ, Sartoni-D'Ambrosia G, Arbique D, Vongpatanasin W, Unger R, Victor RG. Myocardial triglycerides and systolic function in humans: in vivo evaluation by localized proton spectroscopy and cardiac imaging. Magn Reson Med 2003;49:417-423. (Pubitemid 36262808)
12. van der Meer RW, Rijzewijk LJ, Diamant M, Hammer S, Schar M, Bax JJ, Smit JW, Romijn JA, de Roos A, Lamb HJ. The ageing male heart: myocardial triglyceride content as independent predictor of diastolic function. Eur Heart J 2008;29:1516-1522. (Pubitemid 351881987)
13. Naressi A, Couturier C, Devos JM, Janssen M, Mangeat C, de Beer R, Graveron-Demilly D. Java-based graphical user interface for the MRUI quantitation package. Magma 2001;12:141-152. (Pubitemid 32510133)
14. Vanhamme L, van den Boogaart A, Van Huffel S. Improved method for accurate and efficient quantification of MRS data with use of prior knowledge. J Magn Reson 1997;129:35-43. (Pubitemid 127454051)
15. van der Meer RW, Hammer S, Smit JW, Frolich M, Bax JJ, Diamant M, Rijzewijk LJ, de Roos A, Romijn JA, Lamb HJ. Short-term caloric restriction induces accumulation of myocardial triglycerides and decreases left ventricular diastolic function in healthy subjects. Diabetes 2007;56:2849-2853. (Pubitemid 350223617)
16. van der Meer RW, Doornbos J, Kozerke S, Schar M, Bax JJ, Hammer S, Smit JW, Romijn JA, Diamant M, Rijzewijk LJ, de Roos A, Lamb HJ. Metabolic imaging of myocardial triglyceride content: reproducibility of 1H MR spectroscopy with respiratory navigator gating in volunteers. Radiology 2007;245:251-257. (Pubitemid 47417809)
17. Rijzewijk LJ, van der Meer RW, Smit JW, Diamant M, Bax JJ, Hammer S, Romijn JA, de Roos A, Lamb HJ. Myocardial steatosis is an independent predictor of diastolic dysfunction in type 2 diabetes mellitus. J Am Coll Cardiol 2008;52:1793-1799.
18. Lindsey JB, Marso SP. Steatosis and diastolic dysfunction: the skinny on myocardial fat. J Am Coll Cardiol 2008;52:1800-1802.
19. Lee Y, Hirose H, Zhou YT, Esser V, McGarry JD, Unger RH. Increased lipogenic capacity of the islets of obese rats: a role in the pathogenesis of NIDDM. Diabetes 1997;46:408-413. (Pubitemid 27090269)
20. Kankaanpaa M, Lehto HR, Parkka JP, Komu M, Viljanen A, Ferrannini E, Knuuti J, Nuutila P, Parkkola R, Iozzo P. Myocardial triglyceride content and epicardial fat mass in human obesity: relationship to left ventricular function and serum free fatty acid levels. J Clin Endocrinol Metab 2006;91:4689-4695. (Pubitemid 44833458)
21. Bernard CP, Liney GP, Manton DJ, Turnbull LW, Langton CM. Comparison of fat quantification methods: a phantom study at 3.0T. J Magn Reson Imaging 2008;27:192-197.
22. Hu HH, Kim HW, Nayak KS, Goran MI. Comparison of fat-water MRI and single-voxel MRS in the assessment of hepatic and pancreatic fat fractions in humans. Obesity (Silver Spring) 2010;18:841-847.
23. Martin J, Sentis M, Puig J, Rue M, Falco J, Donoso L, Zidan A. Comparison of in-phase and opposed-phase GRE and conventional SE MR pulse sequences in T1-weighted imaging of liver lesions. J Comput Assist Tomogr 1996;20:890-897. (Pubitemid 26392551)
24. Siegelman ES, Rosen MA. Imaging of hepatic steatosis. Semin Liver Dis 2001;21:71-80. (Pubitemid 32240487)
25. Liu CY, Redheuil A, Ouwerkerk R, Lima JA, Bluemke DA. Myocardial fat quantification in humans: evaluation by two-point water-fat imaging and localized proton spectroscopy. Magn Reson Med 2010; 63:892-901.
26. Hernando D, Haldar JP, Sutton BP, Ma J, Kellman P, Liang ZP. Joint estimation of water/fat images and field inhomogeneity map. Magn Reson Med 2008;59:571-580. (Pubitemid 351348228)
27. Kellman P, Hernando D, Shah S, Zuehlsdorff S, Jerecic R, Mancini C, Liang ZP, Arai AE. Multiecho dixon fat and water separation method for detecting fibrofatty infiltration in the myocardium. Magn Reson Med 2009;61:215-221.
28. Reeder SB, Wen Z, Yu H, Pineda AR, Gold GE, Markl M, Pelc NJ. Multicoil Dixon chemical species separation with an iterative least-squares estimation method. Magn Reson Med 2004;51:35-45. (Pubitemid 38095700)
29. Szczepaniak LS, Babcock EE, Schick F, Dobbins RL, Garg A, Burns DK, McGarry JD, Stein DT. Measurement of intracellular triglyceride stores by H spectroscopy: validation in vivo. Am J Physiol 1999; 276(5 Part 1):E977-E989. (Pubitemid 29249618)
30. Madden MC, Van Winkle WB, Kirk K, Pike MM, Pohost GM, Wolkowicz PE. 1H-NMR spectroscopy can accurately quantitate the lipolysis and oxidation of cardiac triacylglycerols. Biochim Biophys Acta 1993;1169:176-182. (Pubitemid 23234594)